Income Statement Grown Rogue International Inc. OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
|
Market Closed -
OTC Markets
15:40:29 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.4601 USD | -2.13% |
|
+0.46% | -10.82% |
| 08-21 | Grown Rogue Shares up 13%, Says Forming Subsidiary to Acquire Cannabis Assets in New York | MT |
| 08-05 | Earnings Flash (GRIN.CN) Grown Rogue International Reports Q2 Revenue $11.3M | MT |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | 9.38M | 17.76M | 21.83M | 27.02M | 32.43M | ||||
Total Revenues | 9.38M | 17.76M | 21.83M | 27.02M | 32.43M | ||||
Cost of Goods Sold, Total | 3.28M | 9.63M | 7.6M | 13.58M | 18.6M | ||||
Gross Profit | 6.1M | 8.12M | 14.22M | 13.44M | 13.83M | ||||
Selling General & Admin Expenses, Total | 3.98M | 5.85M | 8.62M | 10.08M | 11.32M | ||||
Stock-Based Compensation (IS) | 281K | 71K | 626K | 1.31M | 2.39M | ||||
Depreciation & Amortization - (IS) | 180K | 751K | 1.12M | 940K | - | ||||
Amortization of Goodwill and Intangible Assets - (IS) | 5K | - | - | - | 702K | ||||
Other Operating Expenses, Total | 4.45M | 6.67M | 10.37M | 12.32M | 14.42M | ||||
Operating Income | 1.65M | 1.45M | 3.86M | 1.12M | -593K | ||||
Interest Expense, Total | -1.15M | -894K | -1.71M | -2.42M | -1.38M | ||||
Interest And Investment Income | - | - | - | - | 180K | ||||
Net Interest Expenses | -1.15M | -894K | -1.71M | -2.42M | -1.21M | ||||
Income (Loss) On Equity Invest. | - | - | - | -170K | -453K | ||||
Other Non Operating Income (Expenses) | -1.28M | -3.43K | 2.32M | -10.83M | 6.84M | ||||
EBT, Excl. Unusual Items | -772K | 551K | 4.46M | -12.3M | 4.59M | ||||
Merger & Related Restructuring Charges | - | - | - | - | - | ||||
Gain (Loss) On Sale Of Investments | -35.9K | -334K | 2.4M | 3.09M | 247K | ||||
Gain (Loss) On Sale Of Assets | -7.54K | -6.25K | -526K | 50.06K | - | ||||
Asset Writedown | - | - | - | - | - | ||||
Other Unusual Items | -48.64K | 454K | - | 156K | - | ||||
EBT, Incl. Unusual Items | -864K | 665K | 6.34M | -9M | 4.83M | ||||
Income Tax Expense | 151K | 245K | 2.3M | 1.7M | 1.6M | ||||
Earnings From Continuing Operations | -1.01M | 420K | 4.03M | -10.7M | 3.23M | ||||
Net Income to Company | -1.01M | 420K | 4.03M | -10.7M | 3.23M | ||||
Minority Interest | -1.4M | 27.51K | -178K | -607K | -1.5M | ||||
Net Income - (IS) | -2.41M | 447K | 3.86M | -11.3M | 1.73M | ||||
Net Income to Common Incl Extra Items | -2.41M | 447K | 3.86M | -11.3M | 1.73M | ||||
Net Income to Common Excl. Extra Items | -2.41M | 447K | 3.86M | -11.3M | 1.73M | ||||
Per Share Items | |||||||||
Net EPS - Basic | -0.02 | 0 | -0 | -0.05 | 0.01 | ||||
Basic EPS - Continuing Operations | -0.02 | 0 | -0 | -0.05 | 0.01 | ||||
Basic Weighted Average Shares Outstanding | 135M | 169M | 182M | 209M | 243M | ||||
Net EPS - Diluted | -0.02 | 0 | -0 | -0.05 | 0.01 | ||||
Diluted EPS - Continuing Operations | -0.02 | 0 | -0 | -0.05 | 0.01 | ||||
Diluted Weighted Average Shares Outstanding | 135M | 169M | 214M | 209M | 251M | ||||
Normalized Basic EPS | -0.01 | 0 | -0 | -0.04 | 0.01 | ||||
Normalized Diluted EPS | -0.01 | 0 | -0 | -0.04 | 0.01 | ||||
Supplemental Items | |||||||||
EBITDA | 1.84M | 2.2M | 4.97M | 2.06M | 109K | ||||
EBITA | 1.66M | 1.45M | 3.86M | 1.12M | -593K | ||||
EBIT | 1.65M | 1.45M | 3.86M | 1.12M | -593K | ||||
EBITDAR | - | - | - | - | - | ||||
Total Revenues (As Reported) | 9.38M | 17.76M | 21.83M | 27.02M | 32.43M | ||||
Effective Tax Rate - (Ratio) | -17.42 | 36.88 | 36.32 | -18.84 | 33.17 | ||||
Current Domestic Taxes | - | - | 841K | 2.51M | 2.73M | ||||
Total Current Taxes | - | - | 841K | 2.51M | 2.73M | ||||
Deferred Domestic Taxes | - | - | -470K | -814K | -1.12M | ||||
Total Deferred Taxes | - | - | -470K | -814K | -1.12M | ||||
Normalized Net Income | -1.88M | 372K | 2.61M | -8.3M | 1.37M | ||||
Interest on Long-Term Debt | 1.15M | 894K | 286K | 2.42M | 1.38M | ||||
Supplemental Operating Expense Items | |||||||||
Marketing Expenses | - | - | - | - | - | ||||
Selling and Marketing Expenses | - | - | - | - | - | ||||
General and Administrative Expenses | 3.98M | 5.85M | 8.62M | 10.08M | 11.32M | ||||
Research And Development Expense From Footnotes | - | - | - | - | - | ||||
Net Rental Expense, Total | - | - | - | - | - | ||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | ||||
Imputed Operating Lease Depreciation | - | - | - | - | - | ||||
Maintenance & Repair Expenses, Total | - | - | - | - | 320K | ||||
Stock-Based Comp., Other (Total) | 414K | 118K | 626K | 1.31M | 2.39M | ||||
Total Stock-Based Compensation | 414K | 118K | 626K | 1.31M | 2.39M |
Select your edition
All financial news and data tailored to specific country editions
















